Global Human Plasma-Derived Therapeutics Market Growth (Status and Outlook) 2024-2030

August 2024 | 106 pages | ID: GB2680AE46AAEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Human Plasma-Derived Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Human Plasma-Derived Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Human Plasma-Derived Therapeutics market. Human Plasma-Derived Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Plasma-Derived Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Plasma-Derived Therapeutics market.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Key Features:

The report on Human Plasma-Derived Therapeutics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Human Plasma-Derived Therapeutics market. It may include historical data, market segmentation by Type (e.g., Albumin, Immunoglobulin), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Plasma-Derived Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Plasma-Derived Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Human Plasma-Derived Therapeutics industry. This include advancements in Human Plasma-Derived Therapeutics technology, Human Plasma-Derived Therapeutics new entrants, Human Plasma-Derived Therapeutics new investment, and other innovations that are shaping the future of Human Plasma-Derived Therapeutics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Plasma-Derived Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Human Plasma-Derived Therapeutics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Plasma-Derived Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Plasma-Derived Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Plasma-Derived Therapeutics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Plasma-Derived Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Plasma-Derived Therapeutics market.

Market Segmentation:

Human Plasma-Derived Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Albumin
• Immunoglobulin
• Clotting Factor
• Prothrombin Complex
• Others

Segmentation by application

• Hospital
• Clinic
• Research Center

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alkahest
• Baxter
• CSL Behring
• Entegrion, Inc.
• Gammagard
• Grifols
• Kedrion
• Octapharma
• Prometic Life Sciences
• Sanquin
• Takeda

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human Plasma-Derived Therapeutics Market Size 2019-2030
  2.1.2 Human Plasma-Derived Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Human Plasma-Derived Therapeutics Segment by Type
  2.2.1 Albumin
  2.2.2 Immunoglobulin
  2.2.3 Clotting Factor
  2.2.4 Prothrombin Complex
  2.2.5 Others
2.3 Human Plasma-Derived Therapeutics Market Size by Type
  2.3.1 Human Plasma-Derived Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Human Plasma-Derived Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Research Center
2.5 Human Plasma-Derived Therapeutics Market Size by Application
  2.5.1 Human Plasma-Derived Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)

3 HUMAN PLASMA-DERIVED THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Human Plasma-Derived Therapeutics Market Size Market Share by Players
  3.1.1 Global Human Plasma-Derived Therapeutics Revenue by Players (2019-2024)
  3.1.2 Global Human Plasma-Derived Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Human Plasma-Derived Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMAN PLASMA-DERIVED THERAPEUTICS BY REGIONS

4.1 Human Plasma-Derived Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Human Plasma-Derived Therapeutics Market Size Growth (2019-2024)
4.3 APAC Human Plasma-Derived Therapeutics Market Size Growth (2019-2024)
4.4 Europe Human Plasma-Derived Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Human Plasma-Derived Therapeutics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Human Plasma-Derived Therapeutics Market Size by Country (2019-2024)
5.2 Americas Human Plasma-Derived Therapeutics Market Size by Type (2019-2024)
5.3 Americas Human Plasma-Derived Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human Plasma-Derived Therapeutics Market Size by Region (2019-2024)
6.2 APAC Human Plasma-Derived Therapeutics Market Size by Type (2019-2024)
6.3 APAC Human Plasma-Derived Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Human Plasma-Derived Therapeutics by Country (2019-2024)
7.2 Europe Human Plasma-Derived Therapeutics Market Size by Type (2019-2024)
7.3 Europe Human Plasma-Derived Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human Plasma-Derived Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMAN PLASMA-DERIVED THERAPEUTICS MARKET FORECAST

10.1 Global Human Plasma-Derived Therapeutics Forecast by Regions (2025-2030)
  10.1.1 Global Human Plasma-Derived Therapeutics Forecast by Regions (2025-2030)
  10.1.2 Americas Human Plasma-Derived Therapeutics Forecast
  10.1.3 APAC Human Plasma-Derived Therapeutics Forecast
  10.1.4 Europe Human Plasma-Derived Therapeutics Forecast
  10.1.5 Middle East & Africa Human Plasma-Derived Therapeutics Forecast
10.2 Americas Human Plasma-Derived Therapeutics Forecast by Country (2025-2030)
  10.2.1 United States Human Plasma-Derived Therapeutics Market Forecast
  10.2.2 Canada Human Plasma-Derived Therapeutics Market Forecast
  10.2.3 Mexico Human Plasma-Derived Therapeutics Market Forecast
  10.2.4 Brazil Human Plasma-Derived Therapeutics Market Forecast
10.3 APAC Human Plasma-Derived Therapeutics Forecast by Region (2025-2030)
  10.3.1 China Human Plasma-Derived Therapeutics Market Forecast
  10.3.2 Japan Human Plasma-Derived Therapeutics Market Forecast
  10.3.3 Korea Human Plasma-Derived Therapeutics Market Forecast
  10.3.4 Southeast Asia Human Plasma-Derived Therapeutics Market Forecast
  10.3.5 India Human Plasma-Derived Therapeutics Market Forecast
  10.3.6 Australia Human Plasma-Derived Therapeutics Market Forecast
10.4 Europe Human Plasma-Derived Therapeutics Forecast by Country (2025-2030)
  10.4.1 Germany Human Plasma-Derived Therapeutics Market Forecast
  10.4.2 France Human Plasma-Derived Therapeutics Market Forecast
  10.4.3 UK Human Plasma-Derived Therapeutics Market Forecast
  10.4.4 Italy Human Plasma-Derived Therapeutics Market Forecast
  10.4.5 Russia Human Plasma-Derived Therapeutics Market Forecast
10.5 Middle East & Africa Human Plasma-Derived Therapeutics Forecast by Region (2025-2030)
  10.5.1 Egypt Human Plasma-Derived Therapeutics Market Forecast
  10.5.2 South Africa Human Plasma-Derived Therapeutics Market Forecast
  10.5.3 Israel Human Plasma-Derived Therapeutics Market Forecast
  10.5.4 Turkey Human Plasma-Derived Therapeutics Market Forecast
  10.5.5 GCC Countries Human Plasma-Derived Therapeutics Market Forecast
10.6 Global Human Plasma-Derived Therapeutics Forecast by Type (2025-2030)
10.7 Global Human Plasma-Derived Therapeutics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Alkahest
  11.1.1 Alkahest Company Information
  11.1.2 Alkahest Human Plasma-Derived Therapeutics Product Offered
  11.1.3 Alkahest Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Alkahest Main Business Overview
  11.1.5 Alkahest Latest Developments
11.2 Baxter
  11.2.1 Baxter Company Information
  11.2.2 Baxter Human Plasma-Derived Therapeutics Product Offered
  11.2.3 Baxter Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Baxter Main Business Overview
  11.2.5 Baxter Latest Developments
11.3 CSL Behring
  11.3.1 CSL Behring Company Information
  11.3.2 CSL Behring Human Plasma-Derived Therapeutics Product Offered
  11.3.3 CSL Behring Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 CSL Behring Main Business Overview
  11.3.5 CSL Behring Latest Developments
11.4 Entegrion, Inc.
  11.4.1 Entegrion, Inc. Company Information
  11.4.2 Entegrion, Inc. Human Plasma-Derived Therapeutics Product Offered
  11.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Entegrion, Inc. Main Business Overview
  11.4.5 Entegrion, Inc. Latest Developments
11.5 Gammagard
  11.5.1 Gammagard Company Information
  11.5.2 Gammagard Human Plasma-Derived Therapeutics Product Offered
  11.5.3 Gammagard Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Gammagard Main Business Overview
  11.5.5 Gammagard Latest Developments
11.6 Grifols
  11.6.1 Grifols Company Information
  11.6.2 Grifols Human Plasma-Derived Therapeutics Product Offered
  11.6.3 Grifols Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Grifols Main Business Overview
  11.6.5 Grifols Latest Developments
11.7 Kedrion
  11.7.1 Kedrion Company Information
  11.7.2 Kedrion Human Plasma-Derived Therapeutics Product Offered
  11.7.3 Kedrion Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Kedrion Main Business Overview
  11.7.5 Kedrion Latest Developments
11.8 Octapharma
  11.8.1 Octapharma Company Information
  11.8.2 Octapharma Human Plasma-Derived Therapeutics Product Offered
  11.8.3 Octapharma Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Octapharma Main Business Overview
  11.8.5 Octapharma Latest Developments
11.9 Prometic Life Sciences
  11.9.1 Prometic Life Sciences Company Information
  11.9.2 Prometic Life Sciences Human Plasma-Derived Therapeutics Product Offered
  11.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Prometic Life Sciences Main Business Overview
  11.9.5 Prometic Life Sciences Latest Developments
11.10 Sanquin
  11.10.1 Sanquin Company Information
  11.10.2 Sanquin Human Plasma-Derived Therapeutics Product Offered
  11.10.3 Sanquin Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Sanquin Main Business Overview
  11.10.5 Sanquin Latest Developments
11.11 Takeda
  11.11.1 Takeda Company Information
  11.11.2 Takeda Human Plasma-Derived Therapeutics Product Offered
  11.11.3 Takeda Human Plasma-Derived Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Takeda Main Business Overview
  11.11.5 Takeda Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Human Plasma-Derived Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Clotting Factor
Table 5. Major Players of Prothrombin Complex
Table 6. Major Players of Others
Table 7. Human Plasma-Derived Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Human Plasma-Derived Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Table 10. Human Plasma-Derived Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Human Plasma-Derived Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Table 13. Global Human Plasma-Derived Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Human Plasma-Derived Therapeutics Revenue Market Share by Player (2019-2024)
Table 15. Human Plasma-Derived Therapeutics Key Players Head office and Products Offered
Table 16. Human Plasma-Derived Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Human Plasma-Derived Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Human Plasma-Derived Therapeutics Market Size Market Share by Regions (2019-2024)
Table 21. Global Human Plasma-Derived Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Human Plasma-Derived Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Human Plasma-Derived Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Human Plasma-Derived Therapeutics Market Size Market Share by Country (2019-2024)
Table 25. Americas Human Plasma-Derived Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Table 27. Americas Human Plasma-Derived Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Table 29. APAC Human Plasma-Derived Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Human Plasma-Derived Therapeutics Market Size Market Share by Region (2019-2024)
Table 31. APAC Human Plasma-Derived Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Table 33. APAC Human Plasma-Derived Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Table 35. Europe Human Plasma-Derived Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Human Plasma-Derived Therapeutics Market Size Market Share by Country (2019-2024)
Table 37. Europe Human Plasma-Derived Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Table 39. Europe Human Plasma-Derived Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Human Plasma-Derived Therapeutics Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Human Plasma-Derived Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Human Plasma-Derived Therapeutics
Table 48. Key Market Challenges & Risks of Human Plasma-Derived Therapeutics
Table 49. Key Industry Trends of Human Plasma-Derived Therapeutics
Table 50. Global Human Plasma-Derived Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Human Plasma-Derived Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Human Plasma-Derived Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Human Plasma-Derived Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Alkahest Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 55. Alkahest Human Plasma-Derived Therapeutics Product Offered
Table 56. Alkahest Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Alkahest Main Business
Table 58. Alkahest Latest Developments
Table 59. Baxter Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 60. Baxter Human Plasma-Derived Therapeutics Product Offered
Table 61. Baxter Main Business
Table 62. Baxter Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Baxter Latest Developments
Table 64. CSL Behring Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 65. CSL Behring Human Plasma-Derived Therapeutics Product Offered
Table 66. CSL Behring Main Business
Table 67. CSL Behring Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. CSL Behring Latest Developments
Table 69. Entegrion, Inc. Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 70. Entegrion, Inc. Human Plasma-Derived Therapeutics Product Offered
Table 71. Entegrion, Inc. Main Business
Table 72. Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Entegrion, Inc. Latest Developments
Table 74. Gammagard Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 75. Gammagard Human Plasma-Derived Therapeutics Product Offered
Table 76. Gammagard Main Business
Table 77. Gammagard Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Gammagard Latest Developments
Table 79. Grifols Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 80. Grifols Human Plasma-Derived Therapeutics Product Offered
Table 81. Grifols Main Business
Table 82. Grifols Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Grifols Latest Developments
Table 84. Kedrion Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 85. Kedrion Human Plasma-Derived Therapeutics Product Offered
Table 86. Kedrion Main Business
Table 87. Kedrion Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Kedrion Latest Developments
Table 89. Octapharma Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 90. Octapharma Human Plasma-Derived Therapeutics Product Offered
Table 91. Octapharma Main Business
Table 92. Octapharma Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Octapharma Latest Developments
Table 94. Prometic Life Sciences Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 95. Prometic Life Sciences Human Plasma-Derived Therapeutics Product Offered
Table 96. Prometic Life Sciences Main Business
Table 97. Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Prometic Life Sciences Latest Developments
Table 99. Sanquin Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 100. Sanquin Human Plasma-Derived Therapeutics Product Offered
Table 101. Sanquin Main Business
Table 102. Sanquin Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Sanquin Latest Developments
Table 104. Takeda Details, Company Type, Human Plasma-Derived Therapeutics Area Served and Its Competitors
Table 105. Takeda Human Plasma-Derived Therapeutics Product Offered
Table 106. Takeda Human Plasma-Derived Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. Takeda Main Business
Table 108. Takeda Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Human Plasma-Derived Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Plasma-Derived Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Human Plasma-Derived Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Human Plasma-Derived Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Human Plasma-Derived Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Human Plasma-Derived Therapeutics Market Size Market Share by Type in 2023
Figure 10. Human Plasma-Derived Therapeutics in Hospital
Figure 11. Global Human Plasma-Derived Therapeutics Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Human Plasma-Derived Therapeutics in Clinic
Figure 13. Global Human Plasma-Derived Therapeutics Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Human Plasma-Derived Therapeutics in Research Center
Figure 15. Global Human Plasma-Derived Therapeutics Market: Research Center (2019-2024) & ($ Millions)
Figure 16. Global Human Plasma-Derived Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Human Plasma-Derived Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Human Plasma-Derived Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Human Plasma-Derived Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Human Plasma-Derived Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Human Plasma-Derived Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Human Plasma-Derived Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Human Plasma-Derived Therapeutics Value Market Share by Country in 2023
Figure 24. United States Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Human Plasma-Derived Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Human Plasma-Derived Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Human Plasma-Derived Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Human Plasma-Derived Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Human Plasma-Derived Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Human Plasma-Derived Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Human Plasma-Derived Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Human Plasma-Derived Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Human Plasma-Derived Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Human Plasma-Derived Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Human Plasma-Derived Therapeutics Market Size Market Share Forecast by Application (2025-2030)